LNA Sante

LNA Sante SA Formerly known as Le Noble Age. LNA Sante SA, formerly known as Le Noble Age SA is a France-based company that owns and operates retirement homes and complexes for elderly residents. The Company's residences provide care and assistance for elderly people with a variety of needs, from those with a high level of independence, to those who are completely dependent. LNA Sante SA is also engaged in real estate operations. The Company has residences in France and Belgium. LNA Sante SA operates through its several subsidiaries, including Le Parc de Diane Sarl, Institut Medicalise de Mar Vivo, Gerhome, Residence le Point du Jour and the home healthcare service provider ARAIR Assistance, as well as ARAIR Group's support and training services, among others.
  • TickerLNA
  • ISINFR0004170017
  • ExchangeEuronext Paris
  • SectorHealth Care Equipment & Services
  • CountryFrance

Analysts

With a more favourable environment, LNA SANTE SA improves to Slightly Positive

LNA SANTE SA (FR), a company active in the Health Care Providers industry, is favoured by a more supportive environment. The independent financial analyst theScreener has confirmed the fundamental rating of the title, which shows 3 out of 4 stars, as well as its unchanged, moderately risky market behaviour. The title leverages a more favourable environment and raises its general evaluation to Slightly Positive. As of the analysis date November 8, 2019, the closing price was EUR 49.05 and its potential was estimated at EUR 53.69.

Alain William ...
  • Charles Lepetitpas
  • Christophe-Raphaël Ganet
  • Emmanuel Matot
  • Jean-François Granjon
  • Jeremy Garnier
  • Jerôme Bodin
  • Martial Descoutures
  • Nicolas David
  • Olfa Taamallah
  • Oussema Denguir
  • Stephane Houri
  • Yan Derocles

ODDO BHF Small & MIDCAP MORNING NEWS - 11/06/2019

...

Christophe-Raphaël Ganet

LNA Santé : Solid Q3 2019 organic revenue growth – Guidance for organic growth slightly raised

>Q3: robust organic growth –Guidance for organic growth +5% vs +4.5% - LNA Santé has posted Q3 revenues of € 117.8m, representing growth of 6.9% and 6% at constant scope (modest scope effect of +0.9%). For 9M, revenues were up 7.4% to € 348.3m thanks to robust organic growth of 5.5%. Facilities operating at optimal operating efficiency represent 6,519 beds, or 86% of total beds in operation (7,547). The occupancy rate stood above 98% in Q3 2019 thanks to the quality o...

Alain William ...
  • Charles Lepetitpas
  • Christophe-Raphaël Ganet
  • Emmanuel Matot
  • Jean-François Granjon
  • Jeremy Garnier
  • Jerôme Bodin
  • Martial Descoutures
  • Nicolas David
  • Olfa Taamallah
  • Oussema Denguir
  • Stephane Houri
  • Yan Derocles

ODDO BHF Small & MIDCAP MORNING NEWS - 06/11/2019

...

Christophe-Raphaël Ganet

LNA Santé : CA T3 2019 solide sur l’organique – Guidance organique légèrement relevée

>T3 : organique soutenu – Guidance organique ajustée : +5% vs +4,5% - Le CA T3 de LNA Santé a atteint 117,8 M€, affichant une progression de 6,9% et 6% à pc (effet périmètre modéré à +0,9%).Sur les 9 premiers mois de l’exercice, le chiffre d’affaires enregistre une progression de 7,4% à 348,3 M€ grâce à une croissance organique robuste de 5,5%.Les établissements en régime de croisière représentent 6 519 lits, soit 86% du parc en exploitation (7 547 lits). Le...

Bruno de La Rochebrochard

LNA Santé: Q2 revenue: Ahead our expectation with sustained organic. FY organic now expected over 4%.

Brief Comment - LNA Santé: (BUY, Fair Value EUR68 (+24%)) Q2 revenue: Ahead our expectation with sustained organic. FY organic now expected over 4%.

Christophe-Raphaël Ganet

LNA Santé : Solid Q3 2019 organic revenue growth – Guidance for organic growth slightly raised

>Q3: robust organic growth –Guidance for organic growth +5% vs +4.5% - LNA Santé has posted Q3 revenues of € 117.8m, representing growth of 6.9% and 6% at constant scope (modest scope effect of +0.9%). For 9M, revenues were up 7.4% to € 348.3m thanks to robust organic growth of 5.5%. Facilities operating at optimal operating efficiency represent 6,519 beds, or 86% of total beds in operation (7,547). The occupancy rate stood above 98% in Q3 2019 thanks to the quality o...

Christophe-Raphaël Ganet

LNA Santé : CA T3 2019 solide sur l’organique – Guidance organique légèrement relevée

>T3 : organique soutenu – Guidance organique ajustée : +5% vs +4,5% - Le CA T3 de LNA Santé a atteint 117,8 M€, affichant une progression de 6,9% et 6% à pc (effet périmètre modéré à +0,9%).Sur les 9 premiers mois de l’exercice, le chiffre d’affaires enregistre une progression de 7,4% à 348,3 M€ grâce à une croissance organique robuste de 5,5%.Les établissements en régime de croisière représentent 6 519 lits, soit 86% du parc en exploitation (7 547 lits). Le...

Anis Zgaya ...
  • Antoine Boivin-Champeaux
  • Aurelien Sivignon
  • Christophe-Raphaël Ganet
  • Fatma Agnès Hamdani
  • Geoffroy Michalet
  • Jean-François Granjon
  • Jeremy Garnier
  • Khaled Ben Amor
  • Yan Derocles

ODDO BHF Small & MIDCAP MORNING NEWS - 09/20/2019

...

Christophe-Raphaël Ganet

LNA Santé : Good execution - Probably more M&A to come

>Positive announcements for the short and medium term - The three main takeaways from the meeting were:First, the analysis of the figures by the CFO shows that: i/ the mature scope (60 out of 69 facilities) showed an improvement in profitability of 20bp to 12.8%, thanks to retirement homes and home hospital care, and of 60bp excluding the Macron premium, which is good. The other facilities saw their contribution fall (0.6% of revenues at end-June vs 3% in H1 2018...

Anis Zgaya ...
  • Antoine Boivin-Champeaux
  • Aurelien Sivignon
  • Christophe-Raphaël Ganet
  • Fatma Agnès Hamdani
  • Geoffroy Michalet
  • Jean-François Granjon
  • Jeremy Garnier
  • Khaled Ben Amor
  • Yan Derocles

ODDO BHF Small & MIDCAP MORNING NEWS - 20/09/2019

...

1 director sold

A director at Lna Sante Sa sold 1,750 shares at 49.044EUR and the significance rating of the trade was 57/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of board me...

Alain William ...
  • Charles Lepetitpas
  • Christophe-Raphaël Ganet
  • Emmanuel Matot
  • Jean-François Granjon
  • Jeremy Garnier
  • Jerôme Bodin
  • Martial Descoutures
  • Nicolas David
  • Olfa Taamallah
  • Oussema Denguir
  • Stephane Houri
  • Yan Derocles

ODDO BHF Small & MIDCAP MORNING NEWS - 11/06/2019

...

Alain William ...
  • Charles Lepetitpas
  • Christophe-Raphaël Ganet
  • Emmanuel Matot
  • Jean-François Granjon
  • Jeremy Garnier
  • Jerôme Bodin
  • Martial Descoutures
  • Nicolas David
  • Olfa Taamallah
  • Oussema Denguir
  • Stephane Houri
  • Yan Derocles

ODDO BHF Small & MIDCAP MORNING NEWS - 06/11/2019

...

Alfred Glaser ...
  • Christophe-Raphaël Ganet
  • Delphine Brault
  • Laurence Hofmann
  • Martial Descoutures
  • Pierre Corby

ODDO BHF SECURITIES MORNING NEWS – DETAILED COMMENTS 06/27/2019

...

Christophe-Raphaël Ganet ...
  • Jean-François Granjon
  • Jeremy Garnier
  • Laurence Hofmann
  • Oussema Denguir
  • Pierre Corby

ODDO BHF Small & MIDCAP MORNING NEWS - 06/27/2019

...

Christophe-Raphaël Ganet ...
  • Jean-François Granjon
  • Jeremy Garnier
  • Laurence Hofmann
  • Oussema Denguir
  • Pierre Corby

ODDO BHF Small & MIDCAP MORNING NEWS - 27/06/2019

...

With a more favourable environment, LNA SANTE SA improves to Slightly Positive

LNA SANTE SA (FR), a company active in the Health Care Providers industry, is favoured by a more supportive environment. The independent financial analyst theScreener has confirmed the fundamental rating of the title, which shows 3 out of 4 stars, as well as its unchanged, moderately risky market behaviour. The title leverages a more favourable environment and raises its general evaluation to Slightly Positive. As of the analysis date November 8, 2019, the closing price was EUR 49.05 and its potential was estimated at EUR 53.69.

Ford Equity International Rating and Forecast Report

Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind each recommendation and reflect the fundamental and price data as of the last trading day of the week...

Jehanne Leroy

LNA, 19 juin 2019

Le nombre de conventions réglementées conclues avec la société Fidexi (en lien avec Robert Dardanne, administrateur de LNA Santé) est considérable. Or, le principe de conventions conclues avec une société détenue par un mandataire social est une pratique qui paraît peu saine et qui ne peut que susciter des conflits d'intérêts potentiels. Nous nous opposons aux renouvellements des censeurs car leur présence au sein du Conseil leur permet de bénéficier du même niveau d'autorité que les administrateurs tout en n'ayant pas le même niveau de responsabilité (résolutions 6 et 7). Les rémunérations ...

Jehanne Leroy

Proxy Report - 20/06/2018

Parmi les résolutions proposées par la société, six portent sur la rémunération des dirigeants. Même si les montants indiqués semblentraisonnables, l'absence de communication du bonus annuel total ne nous permet pas de les soutenir (résolutions 10 à 15). En raison de montants demandés trop élevés et de la possibilité d'utilisation en période d'o?re publique, la majorité des autorisations d'augmentation de capital demandées sera refusée (résolutions 18 à 21 et 23 et 24).

SRI Quantitative KPIs

Les analyses Gaïa sont des analyses ESG (Environnement, Social, Gouvernance) dediees aux entreprises de tailles intermediaires (PME, ETI) françaises. Elles presentent 120 indicateurs quantitatifs sur les trois derniers exercices.

SRI Company Analysis

Geol analyses are ESG (Environment, Social, Governance) analyses covering European large caps and small and mid caps, listed or non-listed. Those analyses, based on the ESG risks identified, show the qualitative and quantitative performance of issuers, in a ten-page synthesis.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch